Lynn Howard - PRGX Global Chief Human Resource Officer
Executive
Ms. Lynn Howard is Chief Human Resource Officer of the company. Ms. Howard has more than 25 years of human resources experience. Prior to joining the Company, she served as Chief Human Resource Officer for Ciox Health. Previously, she held executive leadership positions with ABILITY Network, Surgical Care Affiliates, and MedAssets since 2019.
Tenure | 5 years |
Professional Marks | MBA |
Phone | 770 779-3900 |
Web | www.prgx.com |
PRGX Global Management Efficiency
The company has return on total asset (ROA) of 4.62 % which means that it generated a profit of $4.62 on every $100 spent on assets. This is normal as compared to the sector avarege. Similarly, it shows a return on stockholder's equity (ROE) of (8.55) %, meaning that it created substantial loss on money invested by shareholders. PRGX Global's management efficiency ratios could be used to measure how well PRGX Global manages its routine affairs as well as how well it operates its assets and liabilities.The company currently holds 41.27 M in liabilities with Debt to Equity (D/E) ratio of 0.73, which is about average as compared to similar companies. PRGX Global has a current ratio of 2.03, suggesting that it is liquid enough and is able to pay its financial obligations when due. Debt can assist PRGX Global until it has trouble settling it off, either with new capital or with free cash flow. So, PRGX Global's shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like PRGX Global sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for PRGX to invest in growth at high rates of return. When we think about PRGX Global's use of debt, we should always consider it together with cash and equity.
Similar Executives
Showing other executives | EXECUTIVE Age | ||
Amy Heidersbach | DHI Group | 55 | |
Josephine Hellschlienger | Abcellera BiologicsInc | N/A | |
Debora MD | Tscan Therapeutics | 48 | |
Frederic Jacotot | Valneva SE ADR | 60 | |
Patrick McKillop | Asure Software | N/A | |
Charon Sr | Ardelyx | N/A | |
Esq JD | Abcellera BiologicsInc | 54 | |
Willard Thomas | VirnetX Holding Corp | N/A | |
Neil MBA | Abcellera BiologicsInc | 54 | |
Kathleen BA | Abcellera BiologicsInc | N/A | |
Leiden MBA | Tscan Therapeutics | N/A | |
Franck MBA | Valneva SE ADR | 57 | |
Eyal Goldstein | Asure Software | 48 | |
MPH MD | Ardelyx | 60 | |
Heather Savelle | Tscan Therapeutics | N/A | |
Ann Hargraves | Tscan Therapeutics | N/A | |
Robert Felsch | Ardelyx | N/A | |
CGA CPA | Abcellera BiologicsInc | N/A | |
Petra Pesendorfer | Valneva SE ADR | 38 | |
Sameer Mathur | VirnetX Holding Corp | N/A | |
Justin McCue | Tscan Therapeutics | N/A |
Management Performance
Return On Equity | -8.55 | |||
Return On Asset | 4.62 |
PRGX Global Leadership Team
Elected by the shareholders, the PRGX Global's board of directors comprises two types of representatives: PRGX Global inside directors who are chosen from within the company, and outside directors, selected externally and held independent of PRGX. The board's role is to monitor PRGX Global's management team and ensure that shareholders' interests are well served. PRGX Global's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, PRGX Global's outside directors are responsible for providing unbiased perspectives on the board's policies.
Michael Cochrane, Sr. VP of Global Client Operations | ||
Gregory Owens, Independent Director | ||
Mylle Mangum, Independent Director | ||
Tushar Sachdev, CIO and Sr. VP of Global Shared Services | ||
Lynn Howard, Chief Human Resource Officer | ||
Daryl Rolley, Senior Vice President and Chief Commercial Officer | ||
Bradley White, Principal Accounting Officer, Controller | ||
Julian Sparkes, Vice President - Alliance and Channels | ||
Joseph Whitters, Independent Director | ||
Michael Reene, Senior Vice President - Growth and Market Development | ||
Jimmy Madden, Senior Vice President of Sales | ||
Frank Scirica, Vice President Commercial Client Relations | ||
Puneet Pamnani, Chief Strategy Officer and Sr. VP | ||
William Kimble, Independent Director | ||
Peter Limeri, CFO and Treasurer | ||
Doug Halka, Vice President General Manager - Commercial Responsible | ||
Matthew Drapkin, Independent Director | ||
David Cole, Independent Director | ||
Anis HadjTaieb, Vice President - Global Retail Sales and Business Development | ||
Deborah Schleicher, CFO, Controller, Treasurer | ||
Ronald Stewart, CEO and President and Director | ||
Steven Rothman, Vice President & Chief Transformation Officer | ||
Victor Allums, Sr. VP, General Counsel and Secretary | ||
Patrick Dills, Independent Chairman of the Board | ||
Kurt Abkemeier, CFO, Controller, Treasurer | ||
Jim Fisher, CIO | ||
Catherine Lee, Senior Vice President - Human Resources | ||
Andy Brabender, Vice President - Business Development | ||
Carol OKelley, Chief Marketing Officer | ||
Salvatore DePrima, Senior Vice President – Growth and Market Development | ||
Kevin Costello, Independent Director | ||
Tony Massanelli, Senior Vice President - Global Commercial Operations |
PRGX Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is PRGX Global a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
Return On Equity | -8.55 | |||
Return On Asset | 4.62 | |||
Profit Margin | (2.95) % | |||
Operating Margin | 11.73 % | |||
Current Valuation | 200.07 M | |||
Shares Outstanding | 23.63 M | |||
Shares Owned By Insiders | 5.09 % | |||
Shares Owned By Institutions | 65.28 % | |||
Number Of Shares Shorted | 197.69 K | |||
Price To Earning | 75.08 X |
Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards PRGX Global in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, PRGX Global's short interest history, or implied volatility extrapolated from PRGX Global options trading.
Becoming a Better Investor with Macroaxis
Macroaxis puts the power of mathematics on your side. We analyze your portfolios and positions such as PRGX Global using complex mathematical models and algorithms, but make them easy to understand. There is no real person involved in your portfolio analysis. We perform a number of calculations to compute absolute and relative portfolio volatility, correlation between your assets, value at risk, expected return as well as over 100 different fundamental and technical indicators.Build Optimal Portfolios
Align your risk with return expectations
Check out Your Equity Center to better understand how to build diversified portfolios. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in price. Note that the PRGX Global information on this page should be used as a complementary analysis to other PRGX Global's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Holdings module to check your current holdings and cash postion to detemine if your portfolio needs rebalancing.
Other Consideration for investing in PRGX Stock
If you are still planning to invest in PRGX Global check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the PRGX Global's history and understand the potential risks before investing.
Idea Optimizer Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio | |
Equity Forecasting Use basic forecasting models to generate price predictions and determine price momentum | |
Premium Stories Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope | |
ETF Categories List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments | |
Portfolio Dashboard Portfolio dashboard that provides centralized access to all your investments | |
Idea Breakdown Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes | |
Bollinger Bands Use Bollinger Bands indicator to analyze target price for a given investing horizon | |
Equity Valuation Check real value of public entities based on technical and fundamental data |